保留精囊的神经保留前列腺切除术与标准神经保留前列腺切除术后的功能结局比较:随机对照试验结果
一项随机II期试验纳入140例早期前列腺癌男性,比较保留精囊的神经保留前列腺切除术与标准神经保留前列腺切除术。术后两组性功能与 urinary 功能评分均无差异,切缘状态与12个月生化复发相似。结果提示保留精囊的前列腺切除术实用性有限。
要点
- 术后两组性功能与 urinary 功能评分无差异。
- 12个月时尿失禁领域评分神经保留组92 vs 神经保留加精囊保留组87.5(p=0.77)。
- 保留精囊未对切缘状态或12个月生化复发产生负面影响。
核心结论
- 在本随机对照试验中,两组控尿与性功能恢复相似。
- 保留精囊未对切缘状态或12个月生化(前列腺特异性抗原)复发产生负面影响。
- 这些结果提示保留精囊的前列腺切除术实用性有限。
研究设计与样本
- 随机II期试验,共纳入140例早期前列腺癌男性,比较保留精囊的神经保留前列腺切除术与标准神经保留前列腺切除术。
- 术前及术后6个月和12个月评估患者报告的性功能与 urinary 功能评分。
- 切缘状态与前列腺特异性抗原复发作为次要结局评估。
主要发现
- 术后两组性功能或 urinary 功能评分无差异。
- 12个月时尿失禁领域评分中位数神经保留组92 vs 神经保留加精囊保留组87.5(p=0.77)。
- 12个月时性功能领域评分中位数神经保留组73.7 vs 神经保留加精囊保留组77.1(p=0.29)。
- 两组切缘状态与12个月生化复发相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Seminal vesicle sparing may reduce the risk of neurovascular bundle injury and improve functional outcomes after prostatectomy. While several observational studies have shown better functional outcomes following seminal vesicle sparing approaches, evidence from randomized trials is lacking. We performed a randomized controlled trial comparing functional and cancer control outcomes between nerve sparing prostatectomy augmented with seminal vesicle sparing and standard nerve sparing prostatectomy. MATERIALS AND METHODS: A total of 140 men with early stage prostate cancer were enrolled in a randomized phase II trial comparing nerve sparing prostatectomy augmented with seminal vesicle sparing to standard nerve sparing prostatectomy. Patient reported sexual and urinary functional scores were assessed prior to surgery, and 6 and 12 months postoperatively. Surgical margin status and prostate specific antigen recurrence were evaluated as secondary outcomes. RESULTS: There were no differences in sexual or urinary function scores after surgery between the study groups. The median urinary incontinence domain score was 92 in the nerve sparing group and 87.5 in the nerve plus seminal vesicle sparing group at 12 months (p = 0.77). Median sexual function domain scores were 73.7 in the nerve sparing group and 77.1 in the nerve sparing plus seminal vesicle sparing group at 12 months (p = 0.29). Margin status and 12-month biochemical recurrence were similar in the groups. CONCLUSIONS: Recovery of continence and sexual function was similar between the groups in this randomized controlled trial. Seminal vesicle sparing did not negatively affect margin status or 12-month biochemical (prostate specific antigen) recurrence. These results suggest limited usefulness of seminal vesicle sparing prostatectomy.
引用
- Gilbert SM, Dunn RL, Miller DC, et al. Functional Outcomes Following Nerve Sparing Prostatectomy Augmented with Seminal Vesicle Sparing Compared to Standard Nerve Sparing Prostatectomy: Results from a Randomized Controlled Trial. J Urol. 2017. PMID: 28392393. doi:10.1016/j.juro.2017.03.133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。